NKGN NKGen EV/EBITDA Multiple
The price history on GURU.Markets shows that NKGen Biotech, Inc. (NKGN) has an EV/EBITDA multiple of . NKGen Biotech, Inc. (NKGN) utilizes automated sterile complexes to scale drug production. The business develops innovative methods to combat dementia and tremors, leveraging protected patents. Meanwhile, the lack of sales is leading to a gradual depletion of cash reserves due to medical trial expenses.
nkgenbiotech.com (NKGN) - metric breakdowns and financial figures
- current price and projected stock value:
- market capitalization data:
- issuer book value statistics:
- debt and liquidity data:
- business earnings and investment ratios data:
NKGN - Company Net Income|Projected Future Earnings NKGen Biotech, Inc.|NKGN - Price to Earnings Ratio|Forward P/E Multiple NKGen Biotech, Inc.|NKGN - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio NKGen Biotech Corp|NKGN - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) NKGen Biotech|NKGN - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months nkgenbiotech.com|NKGN - Earnings per share growth this year|Earnings growth forecast for next year NKGen Biotech, Inc.
Comprehensive company analysis:NKGN (NKGen)
To assess the financial stability of NKGen Biotech, Inc. (NKGN), verifying the business's ability to service its obligations is critical. This indicator correlates the total enterprise value of the company with its operating income, determining the payback period for all assets inclusive of net debt. By analyzing the EV/EBITDA ratio alongside the capital structure, an investor can identify the bankruptcy risk of the biotech firm amid losses and high uncertainty surrounding clinical trials.
Competitor analysis
EV/EBITDA Multiple BIIB (Biogen Corp)|Enterprise Value to EBITDA Multiple Neurocrine Corp|Regencell Bioscience - EV/EBITDA Multiple|Company Value to EBITDA axsome.com|ACADIA Pharmaceuticals Inc. (ACAD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation XENE|Enterprise Value to EBITDA Ratio VKTX|SUPN: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple CPRX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DNLI (denalitherapeutics.com)|EV/EBITDA Multiple HRMY (Harmony Biosciences Holdings, Inc.)|Total Company Value to Operating Income Before Depreciation Ratio Biohaven Ltd (BHVN)|AMLX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Trevi Corp|PRAX (Praxis Precision Medicines) - Enterprise Value to EBITDA Ratio|AVXL: Enterprise Value to Operating Income Before Depreciation Ratio|CBLL (CeriBell) - EV/EBITDA Multiple|Company Value to EBITDA Prothena Corporation PLC PRTA|EV/EBITDA Multiple ALEC|Enterprise Value to EBITDA Ratio Annexon Biosciences Inc. ANNX|EV/EBITDA Multiple OMER (Omeros)|Business Value to Operating Income Before Depreciation NGNE|ACIU: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VYGR (Voyager Therapeutics Inc)|NMRA: EV/EBITDA Multiple|SCLX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tevogen Bio Holdings|Enterprise Value to Operating Income Before Depreciation ACOG (Alpha Cognition Corp)|EV/EBITDA Multiple CGTX|Enterprise Value to EBITDA Ratio Inhibikase Therapeutics Inc IKT|Cassava - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Assertio Holdings (ASRT)|COYA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|VTGN (Vistagen Therapeutics) - Enterprise Value to Operating Income Before Depreciation|ovidrx.com (OVID) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Acumen Pharmaceuticals Inc. (ABOS) - EV/EBITDA Multiple|CRVO (CervoMed Inc) - EV/EBITDA Multiple|ATHE - Enterprise Value to EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Clene Inc. (CLNN)|pepgen.com - Enterprise Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Jupiter Neurosciences JUNS|RLMD: Enterprise Value to Operating Income Before Depreciation|Annovis Bio Corp - EV/EBITDA Multiple|Company Value to EBITDA Grace Therapeutics, Inc.|AIFF (Firefly Neuroscience, Inc) - Enterprise Value to EBITDA Ratio|Klotho Neurosciences (KLTO) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroSense Therapeutics Ltd|RVPH: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MetaVia Inc (MTVA)|NRXS - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Helius Medical Technologies HSDT|PASG: Enterprise Value to Operating Income Before Depreciation|NEUP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|NERV - EV/EBITDA Multiple|ATHA: EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Addex ADXN|ALZN (Alzamend Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA Cyclerion CYCN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Protagenic Therapeutics (PTIX)|pasitheaclinics.com - Enterprise Value to Operating Income Before Depreciation|Cortigent - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ATXI|Brainstorm Cell - EV/EBITDA Multiple|CARA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CHRO: EV/EBITDA Multiple|ELYM - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Intra-Cellular Therapies Inc.|Company Value to EBITDA Longboard LBPH|Enterprise Value to EBITDA Ratio MRNS (Marinus Pharmaceuticals)|Enterprise Value to Operating Income Before Depreciation Ratio NRBO|EV/EBITDA Multiple SAGE (Sage Therapeutics)|Synaptogenix Inc. (SNPX) - Company Value to EBITDA|Trevena, Inc - EV/EBITDA Multiple|Vigil Neuroscience (VIGL) - Enterprise Value to EBITDA Ratio|WENA: EV/EBITDA Multiple|cerevel.com - Business Value to Operating Income Before Depreciation
